”Clean” claims, considered the “new natural” in cosmetic product labeling and advertising, should be avoided unless a company can provide a clear definition and keep it consistent across marketing, says Ronie Schmelz, partner in the Los Angeles office of K&L Gates, LLP.
Clean Beauty, The New ‘Natural,’ Carries Same Litigation Risk – Attorneys
Beauty and personal-care companies using ‘clean’ labeling and advertising should clearly define the term and ensure consistency across marketing messages, attorneys said at the BBB National Program Inc.’s 18 July webinar, ‘Getting Clean Beauty Advertising Right.’
More from United States
More from North America
• By
The Washington State Department of Ecology will try to work with companies that violate the Toxic Free Cosmetics Act, rather than reflexively imposing the $5,000-per-violation fine for first-time offenders, says the law’s implementation planner. She noted financial assistance is available for small businesses, as well as incentives for companies adopting measures “beyond compliance.”
• By
US FDA Office of New Drugs Director Peter Stein says review divisions have made the case that a discussion-only meeting would solicit the necessary input.
• By
Requests for “enforcement actions are not within the scope of FDA’s citizen petition procedures,” CDER says, rejecting petition dosing device firm Parenteral Technologies submitted as it prepares for workshop on Pediatric Research Equity Act requirements for OTC NDA sponsors.